[Molecular biology of sarcoma and therapeutic choices].

Abstract:

:Soft tissue sarcomas (STS) are a set of very heterogeneous tumors with numerous histological categories. The development of the molecular biology allowed identifying recurring molecular anomalies in certain subgroups of sarcomas, being able to represent diagnostic, prognosis and therapeutic tools. The molecular classification of STS includes until today 5 main groups of abnormalities: sarcomas with "simple genomic profile" showing reciprocal (1) chromosomal translocations, (2) activating mutation, (3) inhibitive mutation or (4) simple amplification; (5) sarcomas with "complex genomic profile" can include several tens of molecular abnormalities. The development of new-targeted therapies is based on the identification of a target, specific of a tumors subgroup and involved in carcinogenesis mechanisms and/or tumoral growth. Then, the aim of clinical research is to establish the proof of the concept through clinical trials, demonstrating the benefit brought to the patient and ending in the marketing of the drug. This proof of the concept was clearly established for imatinib, sunitinib and regorafenib in gastrointestinal stromal tumors, for imatinib in dermatofibrosarcoma protuberans and pigmented vilo-nodular synovitis, for denosumab in giant cell tumors of the bone, ending in the authorization to use these new therapies in these indications. It is in progress and promising for anti-IGF-1R in Ewing sarcomas, for crizotinib in myofibroblastic inflammatory tumors, for mTOR inhibitor in PEComas... The role of molecular abnormalities identified in the mechanisms of tumoral progress for sarcomas and their potential therapeutic impact will be detailed.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Dufresne A,Cassier P,Heudel P,Pissaloux D,Wang Q,Blay JY,Ray-Coquard I

doi

10.1016/j.bulcan.2014.12.005

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

6-16

issue

1

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(14)00006-X

journal_volume

102

pub_type

杂志文章,评审
  • [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].

    abstract::We evaluated the efficacy and safety of a monotherapy by piperacillin and sulbactam potentially associated to vancomycin as an empiric antimicrobial therapy in febrile neutropenic patients treated with nephrotoxic chemotherapy for solid tumors. Twenty-three patients were treated during 32 episodes with piperacillin 4 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Abs L,Kattan J,Culine S,Bekradda M,Farhat F,Droz JP

    更新日期:1994-10-01 00:00:00

  • [Prognostic factors in endometrial cancer: apropos of 206 cases treated at the Curie Institute].

    abstract::From January 1, 1983 to December 31, 1990 two hundred and six patients with an invasive, non metastatic endometrial carcinoma were first treated at Institut Curie. Initial tumoral staging (TNM) was as follows: stage Ia: 48%, stage Ib: 31%, stage II: 15% and stage III-IV: 6%. Total hysterectomy or colpohysterectomy was...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Chen Q,de la Rochefordière A,Mouret-Fourme E,Durand JC,Clough K,Asselain B,Labib A,Fenton J

    更新日期:1995-09-01 00:00:00

  • [Preclinical evaluation of anticancer drugs: a model remaining a model!].

    abstract::Two criteria are firstly used in the selection of new anticancer agents:--originality of the mechanism of action and significant experimental antitumor activity in an in vivo animal model. Murine tumors grafted in syngenic mice and human tumor xenografts implanted in nude mice are old models which continue to be widel...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lavelle F

    更新日期:1998-10-01 00:00:00

  • [Primary cerebral non-Hodgkin lymphoma in non-immunocompromised subjects].

    abstract::Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,meta分析

    doi:

    authors: Blay JY

    更新日期:1997-10-01 00:00:00

  • [Obstacles and reticences in the screening of cancer of the cervix by the general practitioner].

    abstract::To have a better understanding of the poor participation rate among general practitioners (GPs) in cervical cancer screening, we have conducted a survey in the department of Bas-Rhin on a small sample of GPs. This helped to explain how they perceived this technical act, the problems or barriers related to it: rate, fu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Weil O,Schaffer P

    更新日期:1994-04-01 00:00:00

  • [Use of tomographic scintigraphy with radio-labelled monoclonal antibodies for detecting human digestive cancers and medullary cancers of the thyroid].

    abstract::Two 131-Iodine radiolabelled monoclonal antibodies were used to perform tomoscintigraphy in 42 patients: 11 patients bearing medullary thyroid cancers and 19 patients bearing gastrointestinal cancers received an antibody directed against carcino-embryonic antigen; 12 patients bearing gastro-intestinal cancers received...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lumbroso J,Berche C,Mach JP,Rougier P,Aubry F,Buchegger F,Lasser P,Parmentier C,Tubiana M

    更新日期:1983-01-01 00:00:00

  • [Gangliosides and cancer].

    abstract::Gangliosides are glycosphingolipids which contain neuraminic acid. Although they are present in the plasma membranes of all cells, gangliosides are expressed differently, both quantitatively and qualitatively, in certain types of cancer. Modifications in ganglioside composition may account for some of the abnormal int...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dumontet C,Portoukalian J

    更新日期:1991-01-01 00:00:00

  • [Long-term occupational situation after cancer: A French registry-based study].

    abstract:INTRODUCTION:Few studies have explored the long-term occupational situation after cancer. The aim of our study were to study the employment status among long-term cancer survivors and to compare it to cancer-free controls from the general population at 5, 10 or 15 years after cancer diagnosis. METHODS:From data of a r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.06.004

    authors: Saim A,Gernier F,Licaj I,Rod J,Velten M,Klein D,Mercier M,Joly F

    更新日期:2020-09-01 00:00:00

  • [Gastrointestinal stromal tumours in pediatrics: a summary of the literature on this orphan disease].

    abstract::Recommendations for the management of gastrointestinal stromal tumours (GIST) in children and adolescents do presently not exist. Thus, a summary of the current literature was conducted serving as a basis for the development of optimal management strategies for childhood GIST. Pediatric cases of GIST may occur sporadi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1296

    authors: Verschuur A,André N,Blay JY

    更新日期:2011-01-01 00:00:00

  • [Novel conventional therapies in onco-hemathology].

    abstract::Cytogenetic, molecular and phenotyping features of malignant hematologic diseases succeeded in improving their management by a more accurate stratification of patients according to several groups of risk and by providing a rational for targeted therapy. Three major types of treatment (excluding cellular therapy) are c...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1412

    authors: Baleydier F,Domenech C,Thomas X

    更新日期:2011-08-01 00:00:00

  • Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

    abstract:BACKGROUND:We analyzed renal cell carcinoma (RCC) brain metastasis (BM) risk factors and compared BM occurrence in metastatic RCC (mRCC) treated with or without anti-angiogenic agents (AA). METHODS:Data from all consecutive metastatic RCC patients (patients) treated in a french cancer center between 1995 and 2008 were...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1672

    authors: Vanhuyse M,Penel N,Caty A,Fumagalli I,Alt M,Zini L,Adenis A

    更新日期:2012-12-01 00:00:00

  • [Nomograms in routine clinical practice: Methodology, interest and limitations].

    abstract::In order to help the clinician, mathematical models including several clinical and pathological variables are proposed in the literature with the aim to predict the occurrence of an event of interest. Nomograms allow individual prognosis for each patient. When they are developed, validated and correctly used, nomogram...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.10.024

    authors: Filleron T,Chaltiel L,Jouve E,Cabarrou B,Gilhodes J,Lusque A,Mery E,Dalenc F,Martinez A

    更新日期:2018-01-01 00:00:00

  • [Study of codon 72 of p53 gene as a risk-factor in cervical cancer in Senegal].

    abstract::Beside human papilloma virus infection, several genetic factors have been involved in susceptibility to cervical cancer. The arginine allele at codon 72 in p53 tumor suppressor gene has been reported to be a risk-factor in different ethnic groups. Our aim was to study this polymorphism as a risk-factor in Senegal. We ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1911

    authors: Ndiaye R,Dem A,Mbaye PM,Guèye PM,Diop G,Diop PA,Faye O

    更新日期:2014-09-01 00:00:00

  • Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.

    abstract::To show the nature and magnitude of EKG anomalies subsequent to 5-fluorouracil (5FU) administration and determine whether the onset is dependent on a pre-existing cardiovascular pathological condition. 1,350 patients were treated by 5FU between 1995 and 2000. EKG were recorded in all patients before each administratio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tsibiribi P,Descotes J,Lombard-Bohas C,Barel C,Bui-Xuan B,Belkhiria M,Tabib A,Timour Q

    更新日期:2006-03-01 00:00:00

  • [Brachytherapy for prostate cancer: old concept, new techniques].

    abstract::Whereas it has been proposed almost one century ago, brachytherapy for prostate cancer has only recently emerged, especially thanks to endorectal echography, allowing to visualize seed implantation, to the development of seeds for permanent delivery and of micro-sources for high-dose rate delivery, and also to the dev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cosset JM,Flam T,Thiounn N,Rosenwald JC,Pontvert D,Timbert M,Solignac S,Chauveinc L

    更新日期:2006-08-01 00:00:00

  • [The contribution of PET to radiation treatment planning].

    abstract::Advances in medical imaging have greatly enhanced the speciality of radiation oncology by allowing more healthy tissue to be speared for better tumour coverage. Positron emission tomography (PET) with the glucose analogue [18F]-fluoro-2-deoxy-D-glucose (FDG) is a functional imaging method that has become widely used i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Belkacémi Y,Lartigau E,Kerrou K,Carpentier P,Taïeb S,Giraud P

    更新日期:2007-01-01 00:00:00

  • [Association of radiotherapy and hormonotherapy in locally advanced prostate cancer].

    abstract::Combination of radiotherapy and androgen deprivation is now considered as the standard of care for patients with a localized prostate cancer but poor prognostic factors. Two groups of randomized trials have led to this recommendation. Some have compared radiotherapy alone versus hormonal treatment and radiotherapy: th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1567

    authors: Quero L,Wong-Hee-Kam S,Rivera S,Hennequin C

    更新日期:2012-07-01 00:00:00

  • [CD44 expression: a new prognostic factor in neuroblastoma].

    abstract::CD44 gene products are potential markers of aggressiveness in different tumor models, a result which prompted us to study clinical neuroblastoma (NB) specimens. CD44 expression was determined by immunostaining of 52 NB with a monoclonal antibody (J173) directed against an epitope common to all CD44 isoforms. All tumor...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Combaret V,Lasset C,Bouvier R,Frappaz D,Thiesse P,Rebillard AC,Philip T,Favrot MC

    更新日期:1995-01-01 00:00:00

  • [Medico-economical assessment in cancerology].

    abstract::In recent studies, the economic criteria has begun to be integrated to the appraisal in cancerology. The question asked by the economist can be framed as follows: what incremental cost should the collectivity or the health insurance system consent, in order to improve the care of cancer patients? This involves first t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lebrun T,Selke B,Bercez C,Bonneterre ME,Lenne X,Sailly JC,Bonneterre J

    更新日期:1997-05-01 00:00:00

  • [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals, as well as private clinics and medical specialty societies. ...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Denoux Y,Blanc-Vincent MP,Simony-Lafontaine Jl,Verriele-Beurrier V,Briffod M,Voigt JJ

    更新日期:2002-04-01 00:00:00

  • [Improving doctor's communication skills in oncology: review and future perspectives].

    abstract::The aim of this review is to discuss the different communication skills training designed to physician interactions with cancer patients. The development of medicine and chronic cancer treatments indicates the need to improve communication skills that combine appropriate assessment, information and support. Literature...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Libert Y,Conradt S,Reynaert C,Janne P,Tordeurs D,Delvaux N,Fontaine O,Razavi D

    更新日期:2001-12-01 00:00:00

  • [Axillary lymphadenectomy prepared by fat aspiration versus functional axillary lymphadenectomy: preliminary results of a randomized prospective study].

    abstract::The objective of this study is to compare morbidity between 2 surgical procedures of axillary clearance: functional lymphadenectomy by classical dissection versus axillary dissection prepared by liposuction (Suzanne's procedure). Two hundred consecutive patients treated for breast cancer were included in a prospective...

    journal_title:Bulletin du cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Giard S,Laurent JC,Dron AM,Lefebvre D

    更新日期:1997-03-01 00:00:00

  • [Tamoxifen and endometrial adenocarcinoma].

    abstract::The authors report a case of endometrial carcinoma treated with tamoxifen introduced after normal initial uterine curettage. Based on recent experimental and clinical data, the importance of a gynecological follow-up in anti-estrogen therapy is emphasized. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Rodier JF,Camus E,Janser JC,Renaud R,Rodier D

    更新日期:1990-01-01 00:00:00

  • [Ovarian cancer in France. Epidemiological, clinical and histological status].

    abstract::With 2 436 deaths in 1979, ovarian cancer is relatively infrequent in France comprising but 5 per cent of female mortality from malignant disease. However, the rate of increase in mortality is considerable, 70 per cent between 1955 and 1979 or 2,9 per cent per year, greater than that for female bladder and breast canc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Berlie J,Tournade MF,Chauvergne J,Bastien H

    更新日期:1983-01-01 00:00:00

  • [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].

    abstract::Receptor assays for both ER and PR in breast cancer specimens is used either to choose adjuvant therapy during the first treatment, or to choose hormone therapy for metastatic patients, or for the diagnosis of tumors. Whereas biochemical methods, either by radioligand or by monoclonal antibodies, have progressed over ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J

    更新日期:1996-12-01 00:00:00

  • [Modification of the cellular cytoskeleton and hepatic tumor promotion].

    abstract::Non transformed epithelial hepatic cells (established cell line and adult rat hepatocytes) treated by liver tumor promoters, phenobarbital and biliverdin, for 24 and 48 h showed a fragmentation and loss of F-actin and a depolymerisation of microtubules. This pattern closely resembles that of transformed cells which we...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Decloître F,Martin M,Ouldelhkim M,Nizard C

    更新日期:1990-01-01 00:00:00

  • [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].

    abstract::Twenty-five adult patients, 15 men and 10 women, with a median age of 49, and presenting with metastatic or locally advanced soft tissue sarcomas, have been treated with chemotherapy protocol combining cisplatinum, 100 mg/m2, vindesine, 4 mg/m2, and either adriamycin, 50 mg/m2 (APEL) (16 patients), or epirubicin, 100 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Becouarn Y,Bui BN,Kerbrat P,Chauvergne J,Brunet R,Robert J

    更新日期:1987-01-01 00:00:00

  • [Secondary non-Hodgkin's lymphomas].

    abstract::Developing a secondary non Hodgkin's lymphoma (NHL) more than 12 months after treatment for first cancer, is uncommon. Secondary NHL occurs sometimes after chronic lymphatic leukemia or Hodgkin's disease. The 20 years cumulative incidence rate is 3-5% after Hodgkin's disease. Secondary NHL seems less frequent after an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Cappelaere P

    更新日期:1998-03-01 00:00:00

  • Image guided radiotherapy for prostate cancer.

    abstract::The purpose of external beam radiotherapy is to sterilize malignant tumours and at the same time to avoid complications by radiation injury to the surrounding healthy tissues. Modern radiation techniques in recent years have allowed to safely escalate the dose by approximately 10% for the treatment of prostate cancer,...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2008.0599

    authors: Soete G,Verellen D,Storme G

    更新日期:2008-03-01 00:00:00

  • [Biology of small-cell bronchogenic carcinoma: recent advances].

    abstract::In the last ten years considerable progress has been made in small-cell lung carcinoma (SCLC) biology, along with the technical progress made in molecular biology. This progress now allows us to propose a model for the genesis and the development of this type of tumor. Tobacco, the principal causal factor plays a dual...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Levy R,Andrieu JM,Even P

    更新日期:1992-01-01 00:00:00